OBGYN EHR Podcasts
Podcast: EHR Meaningful Use Update In this podcast, Justin Barnes, of the EHR Association and Greenway Medical Technologies, explains CMS’ final rule for meaningful use criteria for EHR incentives.
Podcast: EHR Meaningful Use Update
In this podcast, Justin Barnes, of the EHR Association and Greenway Medical Technologies, explains CMS’ final rule for meaningful use criteria for EHR incentives.
Podcast: Training Health IT Workers
The federal government’s commitment to encourage more health information technology means there is a need for some 50,000 health IT workers in the next five years. One organization answering that call is the Oregon Institute of Technology, which just launched a health informatics degree program.
Podcast: Confused about Meaningful Use?
In this podcast, Robert Tennant, senior policy advisor for the Medical Group Management Association, explains the EHR meaningful use draft criteria.
Podcast: EHR Incentives
In this podcast, Justin Barnes, chairman of the HIMSS Electronic Health Record Association and vice president of marketing and government affairs at Greenway Medical Technologies, explains the EHR incentives.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
